Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceuticals ranked by total liabilities, at DKK 933.9B, ahead of Pfizer (DKK 826.3B) and Johnson & Johnson (DKK 801B). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieDKK 933.9B
- Median
- DKK 14.2B
- Combined market value
- DKK 35.02T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | DKK 933.9B | DKK 3.51T | DKK 1,985.20 | 0.42% down | 26% up | ||
| 2 | PfizerPFE · Health Care | DKK 826.3B | DKK 1.1T | DKK 193.77 | 0.02% up | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | DKK 801B | DKK 4.56T | DKK 1,895.01 | 0.16% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | DKK 585B | DKK 8.59T | DKK 9,644.66 | 0.10% up | 35% up | ||
| 5 | Merck & CoMRK · Health Care | DKK 573.2B | DKK 2.36T | DKK 957.17 | 1.95% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | DKK 486.9B | DKK 847.8B | DKK 414.77 | 0.73% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | DKK 444.9B | DKK 1.91T | DKK 1,231.26 | 0.74% down | 2% up | ||
| 8 | NovartisNVS · Health Care | DKK 438.4B | DKK 2.03T | DKK 1,072.55 | 1.01% down | 25% up | ||
| 9 | SanofiSNY · Health Care | DKK 416.1B | DKK 777.2B | DKK 323.69 | 0.04% up | 4% down | ||
| 10 | GSKGSK · Health Care | DKK 408.1B | DKK 671.6B | DKK 335.05 | 0.01% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | DKK 352.4B | DKK 1.21T | DKK 274.71 | 0.86% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | DKK 344.5B | DKK 468.1B | DKK 146.53 | 0.55% down | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | DKK 231.1B | DKK 1.23T | DKK 712.75 | 0.05% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 223.5B | DKK 340B | DKK 291.41 | 0.47% up | 74% up | ||
| 15 | ViatrisVTRS · Health Care | DKK 153B | DKK 160.7B | DKK 140.20 | 0.71% up | 96% up | ||
| 16 | GrifolsGRFS · Health Care | DKK 91.5B | DKK 40B | DKK 58.75 | 0.00% | 1% up | ||
| 17 | ZoetisZTS · Health Care | DKK 82.6B | DKK 232.5B | DKK 572.29 | 0.71% up | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | DKK 67.4B | DKK 269.4B | DKK 468.61 | 0.23% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | DKK 63.3B | DKK 679.5B | DKK 6,568.12 | 0.74% up | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 50B | DKK 105B | DKK 1,635.68 | 0.18% down | 37% up | ||
| 21 | GenmabGMAB · Health Care | DKK 47.8B | DKK 218B | DKK 353.50 | 0.06% down | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | DKK 47.5B | DKK 924B | DKK 3,644.61 | 0.22% up | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | DKK 46.4B | DKK 89.9B | DKK 179.78 | 2.17% up | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | DKK 28.4B | DKK 142.6B | DKK 1,064.72 | 0.06% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | DKK 26.1B | DKK 318.5B | DKK 2,788.66 | 0.87% down | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | DKK 25B | DKK 50.8B | DKK 145.72 | 1.36% up | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | DKK 21.1B | DKK 34.3B | DKK 409.97 | 0.22% down | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | DKK 20.7B | DKK 31.2B | DKK 187.20 | 2.00% up | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | DKK 20.5B | DKK 102.1B | DKK 524.30 | 0.29% up | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 14.4B | DKK 84.8B | DKK 101.70 | 0.95% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | DKK 14.2B | DKK 49.4B | DKK 354.35 | 0.78% up | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | DKK 11.1B | DKK 121B | DKK 1,845.04 | 0.06% down | 28% up | ||
| 33 | InsmedINSM · Health Care | DKK 10.4B | DKK 182.3B | DKK 831.03 | 0.18% up | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | DKK 10.3B | DKK 77.8B | DKK 401.49 | 0.80% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 6B | DKK 41.5B | DKK 293.29 | 0.22% up | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | DKK 5.3B | DKK 169.4B | DKK 3,977.18 | 0.03% up | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | DKK 5B | DKK 22.2B | DKK 114.29 | 4.22% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | DKK 4.5B | DKK 52.8B | DKK 314.46 | 1.64% up | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 4.5B | DKK 66.5B | DKK 2,862.32 | 0.36% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | DKK 4.1B | DKK 48.9B | DKK 930.01 | 0.49% up | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | DKK 3.7B | DKK 40.5B | DKK 2,023.59 | 1.18% up | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | DKK 3.6B | DKK 40.7B | DKK 623.07 | 0.46% down | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | DKK 3.3B | DKK 33.3B | DKK 347.03 | 0.23% down | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | DKK 2.8B | DKK 191.7B | DKK 264.51 | 0.38% up | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | DKK 2.8B | DKK 65.3B | DKK 432.08 | 1.22% up | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | DKK 2.1B | DKK 33.5B | DKK 192.58 | 1.58% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 1.4B | DKK 54.7B | DKK 789.03 | 0.60% down | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 1.3B | DKK 51.5B | DKK 655.85 | 1.30% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | DKK 1.3B | DKK 52.6B | DKK 480.97 | 0.83% up | 8% down | ||
| 50 | ABIVAXABVX · Health Care | DKK 975.3M | DKK 49.6B | DKK 566.09 | 1.29% up | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | DKK 733.6M | DKK 27.5B | DKK 200.61 | 0.31% up | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | DKK 628.5M | DKK 57.5B | DKK 71.85 | 1.08% down | 36% down | ||
| 53 | ErascaERAS · Health Care | DKK 483.2M | DKK 33B | DKK 94.01 | 0.58% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | DKK 425.8M | DKK 61.3B | DKK 645.97 | 1.16% up | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | DKK 406.9M | DKK 58.1B | DKK 2,077.78 | 0.06% up | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | DKK 364.1M | DKK 56B | DKK 857.37 | 1.03% up | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | DKK 255.4M | DKK 33.5B | DKK 594.21 | 0.36% up | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | DKK 206.6M | DKK 31.5B | DKK 287.50 | 0.46% up | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | DKK 113.6M | DKK 45.6B | DKK 672.18 | 2.52% up | 241% up | ||
| 60 | Belite BioBLTE · Health Care | DKK 68.5M | DKK 43.6B | DKK 1,073.64 | 0.00% | 31% up | ||
| 61 | VeradermicsMANE · Health Care | DKK 62.3M | DKK 36.3B | DKK 860.88 | 0.46% up | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8073 DKK).
Questions and answers
Which pharmaceuticals rank first by total liabilities?
AbbVie (DKK 933.9B), Pfizer (DKK 826.3B) and Johnson & Johnson (DKK 801B) are the top three of the 61 pharmaceuticals ranked by total liabilities as of 18 Nov 2026, 14:39 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of DKK 35.02T as of 18 Nov 2026, 14:39 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.